Gerresheimer AG: Business Overview, Financials & Competitive Analysis
Gerresheimer AG scores 5/10 on the AskCyborg Cyborg Score (Mixed). Established healthcare packaging leader navigating turnaround challenges with uncertain near-term execution and solvency concerns offsetting strategic positioning in resilient end markets. Shares fell 11% after the company cut its 2025 guidance for the third time this year. Gerresheimer AG's solvency score is 32/100. The company faces significant operational challenges and.
What is Gerresheimer AG's industry? Gerresheimer AG (gerresheimer.com) operates in Healthcare Packaging & Drug Delivery Devices. AskCyborg classifies Gerresheimer AG under Healthcare Packaging & Drug Delivery Devices in its company registry.
Gerresheimer specializes in producing glass and plastic containers, including vials, ampoules, and cartridges, which are crucial for delivering drugs and vaccines safely to patients worldwide. The company's offerings ...
Cyborg Score thesis
Established healthcare packaging leader navigating turnaround challenges with uncertain near-term execution and solvency concerns...
Read the full analyst-debate transcript →Get the Latest Gerresheimer AG Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeGerresheimer AG Overview
Pro stress-test →Gerresheimer specializes in producing glass and plastic containers, including vials, ampoules, and cartridges, which are crucial for delivering drugs and vaccines safely to patients worldwide. The company's offerings extend to complex drug delivery devices like insulin pens and inhalers. This strategic alignment positions it well amid growing global health needs and an aging population, driving steady demand for its high-margin products.
Strategic Profile
Pro stress-test →Gerresheimer's business model thrives on close partnerships with pharmaceutical giants, crafting tailor-made solutions for diverse therapeutic areas. A comprehensive transformation program is being implemented, including cost reductions, operational improvements, and a new segmentation starting in 2026. The company is preparing to carve out and sell the Moulded Glass business, with new leadership in place.
Competitive Landscape
Pro stress-test →The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Primary competitors include SCHOTT Pharma and Stevanato Group in pharmaceutical packaging. Gerresheimer maintains competitive advantages through integrated drug delivery solutions, but faces pricing pressures and market consolidation.
Industry Context
Gerresheimer AG operates in Healthcare Packaging & Drug Delivery Devices.
Key facts
Founded: 1864 · Headquarters: Düsseldorf, Germany · Employees: 12,142 · Revenue: €2.04B (2024)